Dendreon Corp fka DNDNQ

[DewDiligence]

>FDA Approval in the next 8 months...<

Let’s see… the 9902b interim trigger will probably occur in 12-18 months (the later, the better for DNDN). Add 3-6 months to process the data and submit it to the FDA (assuming the interim threshold is met). Add another 6 months for the FDA review and you have 21-30 months in all.

So how does DNDN accomplish 21-30 months of work in only 8 months?

If they can do that, they must have a time-compression machine and the stock must be seriously undervalued.